$2.69
Price
$1.1B
Market Cap
—
P/E Ratio
-4.4
Forward P/E
$-1.19
EPS (TTM)
—
Dividend Yield
$301M
Cash
$58M
Total Debt
397M
Shares Out
$1.64
$6.50
52-Week Range
Institutional Ownership of IOVANCE BIOTHERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for IOVANCE BIOTHERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for IOVANCE BIOTHERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $0
0
Buys
0
Sells
+0
Net
0
Grants
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 02, 2025 | Igor Bilinsky | Chief Operating Officer | EXERCISE | 3.5K | — | — |
| Dec 02, 2025 | Finckenstein Friedrich Graf | Chief Medical Officer | EXERCISE | 3.9K | — | — |
| Dec 02, 2025 | Frederick G Vogt | Interim CEO & General Counsel | EXERCISE | 10.4K | — | — |
| Dec 01, 2025 | Raj K. Puri | Chief Regulatory Officer | EXERCISE | 5.5K | — | — |
| Dec 01, 2025 | Finckenstein Friedrich Graf | Chief Medical Officer | EXERCISE | 8.8K | — | — |
| Dec 01, 2025 | Frederick G Vogt | Interim CEO & General Counsel | EXERCISE | 41.7K | — | — |
| Dec 01, 2025 | Igor Bilinsky | Chief Operating Officer | EXERCISE | 8.8K | — | — |
| Sep 02, 2025 | Finckenstein Friedrich Graf | Chief Medical Officer | EXERCISE | 12.7K | — | — |
| Sep 02, 2025 | Frederick G Vogt | Interim CEO & General Counsel | EXERCISE | 52.1K | — | — |
| Sep 02, 2025 | Raj K. Puri | Chief Regulatory Officer | EXERCISE | 5.5K | — | — |
| Sep 02, 2025 | Igor Bilinsky | Chief Operating Officer | EXERCISE | 12.3K | — | — |